June 16, 2025 | A new study conducted by Sunstone Therapies suggests that a single dose of psilocybin, combined with psychological support, can provide sustained relief from depression for some cancer patients.
Kimberly Roddy, MBA, Co-Founder and COO of Sunstone Therapies Kimberly Roddy is the Co-Founder and Chief Operations Officer of Sunstone […]
September 12, 2022 | Recognizing the limitations of conventional oncology in addressing end-of-life psychological distress, Dr. Manish Agrawal and his team at Sunstone Therapies are advancing research into psilocybin-assisted therapy for patients with advanced cancer. In a recent clinical trial, a single psilocybin dose combined with group therapy resulted in a clinically significant reduction in depression symptoms for 80% of participants—highlighting the potential of psychedelic-assisted interventions to enhance quality of life and psychological well-being in palliative care settings.